Stroke, Vol 23, 1118-1123, Copyright © 1992 by American Heart Association
R Prado, BD Watson, J Kuluz and WD Dietrich
BACKGROUND AND PURPOSE: We determined the effects of inhibiting the
production of cerebral endothelium-derived nitric oxide on pial artery
diameter, cortical blood flow, and vascular morphology. METHODS: An
inhibitor of endothelium-derived nitric oxide synthesis, NG-nitro-L-
arginine methyl ester hydrochloride (L-NAME), or an equivalent volume of
0.9% saline was infused into rats intra-arterially in a retrograde fashion
via the right external carotid artery at a rate of 3 mg/kg/min to a total
dose of 190 mg/kg or intravenously at 1 mg/kg/min to a total dose of 15
mg/kg. Large pial arteries were continuously visualized through an
operating microscope, and cortical cerebral blood flow was monitored by
laser-Doppler flowmetry. To localize areas of morphological interest, the
protein tracer horseradish peroxidase was injected 15 minutes before
termination of the L-NAME infusion and the rats were perfusion-fixed 15
minutes later for light and electron microscopic analysis. RESULTS:
Infusion of L-NAME significantly raised arterial blood pressure at both
doses (for 190 mg/kg, from 103.2 +/- 3.4 to 135 +/- 3.4 mm Hg; for 15
mg/kg, from 125 +/- 2.8 to 144.4 +/- 4.0 mm Hg). Pial arteries constricted
within 10 minutes after the start of the intracarotid infusion to 40% of
the preinfusion diameter, while cortical cerebral blood flow decreased to
an average of 72.5% of that at baseline. Morphological abnormalities in the
experimental rats included microvascular stasis and focal areas of
blood-brain barrier disruption to protein. Ultrastructural examination of
cortical leaky sites revealed constricted arterioles with many endothelial
pinocytotic vesicles and microvilli. CONCLUSIONS: These observations
suggest that inhibition of endothelium-derived nitric oxide synthesis
affects the relation between cerebral arterial diameter and cerebral blood
flow and can lead to subtle cerebral vascular pathological changes
consistent with focal brain ischemia.
ARTICLES
Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats
Cerebral Vascular Disease Research Center, University of Miami School of Medicine, FL 33101.
This article has been cited by other articles:
![]() |
H. D. Bauser-Heaton and H. G. Bohlen Cerebral microvascular dilation during hypotension and decreased oxygen tension: a role for nNOS Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2193 - H2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Predescu, S. Predescu, and A. B. Malik Transport of nitrated albumin across continuous vascular endothelium PNAS, October 15, 2002; 99(21): 13932 - 13937. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Calingasan, L. C. H. Park, L. L. Calo, R. R. Trifiletti, S. E. Gandy, and G. E. Gibson Induction of Nitric Oxide Synthase and Microglial Responses Precede Selective Cell Death Induced by Chronic Impairment of Oxidative Metabolism Am. J. Pathol., August 1, 1998; 153(2): 599 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iida, H. Iida, S. Dohi, M. Takenaka, H. Fujiwara, and R. J. Traystman Mechanisms Underlying Cerebrovascular Effects of Cigarette Smoking in Rats In Vivo • Editorial Comment Stroke, August 1, 1998; 29(8): 1656 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. French II, D. Kenny, J. P. Scott, R. G. Hoffmann, J. D. Wood, A. G. Hudetz, and C. A. Hillery Mechanisms of Stroke in Sickle Cell Disease: Sickle Erythrocytes Decrease Cerebral Blood Flow in Rats After Nitric Oxide Synthase Inhibition Blood, June 15, 1997; 89(12): 4591 - 4599. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Iadecola, F. Zhang, R. Casey, H. B. Clark, M. E. Ross, and R. C Kukreja Inducible Nitric Oxide Synthase Gene Expression in Vascular Cells After Transient Focal Cerebral Ischemia Stroke, August 1, 1996; 27(8): 1373 - 1380. [Abstract] [Full Text] |
||||
![]() |
R. J. Traystman, L. E. Moore, M. A. Helfaer, S. Davis, K. Banasiak, M. Williams, and P. D. Hurn Nitro-L-Arginine Analogues : Dose- and Time-Related Nitric Oxide Synthase Inhibition in Brain Stroke, May 1, 1995; 26(5): 864 - 869. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |